Curia Unveils Brand Refresh at CPHI WW in Milan
07 oct. 2024 09h49 HE
|
Curia Global, Inc.
Curia refreshes its brand with an updated brand hierarchy, refined messaging and revamped website, highlighting its key capabilities.
ProductLife Group Acquires IntiQuan, Strengthening Global Drug Development Capabilities
07 oct. 2024 03h16 HE
|
Groupe Product Life
ProductLife Group (PLG) is pleased to announce the acquisition of IntiQuan AG, a premier Swiss boutique specializing in pharmacometric services.
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
04 oct. 2024 07h20 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
01 oct. 2024 08h00 HE
|
Halberd Corp.
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
01 oct. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation...
Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider
27 sept. 2024 09h24 HE
|
SNS Insider pvt ltd
Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Market Size & Growth Analysis: According to SNS Insider, The Biopharmaceutical Market Size was valued at USD 572.33 Billion in 2023...
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
25 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
ADR Ratio Change
19 sept. 2024 16h30 HE
|
Biodexa Pharmaceuticals PLC
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19 sept. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
11 sept. 2024 08h00 HE
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD